In the past 20 years the management of peptic ulcer bleeding has been revolutionized by effective endoscopic hemostasis and potent acid-suppressing agents. The author of this Review considers the roles that risk stratification, pharmacologic therapy, endoscopic therapy and surgery now have to play in the management of this common and potentially fatal condition.
